HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Vivo UVA Sunscreen Tests "Clinically Irrelevant...Unethical" - Diffey

This article was originally published in The Rose Sheet

Executive Summary

The use of in vivo methods for UVA sunscreen testing is "clinically irrelevant" and "unethical," Brian Diffey, PhD, Newcastle General Hospital, maintained at the American Association of Dermatology UVA consensus conference in Washington, D.C. Feb. 4.
Advertisement

Related Content

UVA Critical Wavelength Testing Plus In Vivo Method Recommended By AAD
UVA Critical Wavelength Testing Plus In Vivo Method Recommended By AAD
UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey
UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey
L'Oreal Critical Wavelength Criticism Based On "Flawed" Analysis - P&G
L'Oreal Critical Wavelength Criticism Based On "Flawed" Analysis - P&G
UVA critical wavelength method inadequate to predict potential UVA absorption -- L'Oreal.
UVA critical wavelength method inadequate to predict potential UVA absorption -- L'Oreal.
Advertisement
UsernamePublicRestriction

Register

RS007649

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel